人福医药：大信会计师事务所关于人福医药2023年度募集资金存放与实际使用情况审核报告

2023

[2020]2562

89,047,195

1.0011.23/999,999,999.8522,794,247.01977,205,752.84

[2021]2-00005

202180,245.392022

7,265.7920237,944.04202312312,569.65

304.30

22022

()

20212

80%

97,720.58

7,944.04

-

95,455.23

-

(1)

(2)

(3)

(2)-(1)

%(4)

(2)/(1)

47,522.00

47,522.00

47,522.00

7,944.04

45,256.65

-2,265.35

95.23

20236

63,129.99

52,478.00

50,198.58

50,198.58

50,198.58

100.00

100,000.00

97,720.58

97,720.58

7,944.04

95,455.23

-2,265.35

2021226

89,664,085.15

[2021]2-00024